Source: International Congress 2014 – Animal models in respiratory drug development
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Vasquez, A. Lightfoot, C. Page (London, United Kingdom). A molecule derived from mycobacterium tuberculosis Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice. Eur Respir J 2014; 44: Suppl. 58, 1795

Member's Comments

No comment yet.

Related content which might interest you: cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Rapamycin protects OVA induced asthma in mice through regulating autophagy Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 Anti-inflammatory effects of the novel phosphodiesterase type 4 inhibitor CHF6001 on COPD alveolar macrophages and lung tissue Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Anti-inflammatory action of Gibberellin in lung epithelial cells is mediated by modification of NF-κB related kinase expression Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 Role of peroxiredoxin 6 in lipopolysaccharide-induced mucin production in mice Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013 Year: 2013 Recombinant human pulmonary surfactant protein-D (rhSP-D) modulates Th2 responses and suppresses IgE-facilitated allergen binding to B cells Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Resveratrol upregalates PTEN and inhibits MUC5AC expression in ovalbumin (OVA)-induced asthma model mice Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 The human cathelicidin LL37 and mitochondrial DAMPs induce airway inflammation in epithelial cells and mice Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Glucocorticoid-induced transcriptional regulators in human airway cells and airways Source: International Congress 2016 – Studies in airway cell biology Year: 2016 CRAC channel inhibition by RP3128 ameliorates airway hyper-reactivity in antigen sensitized mice and guinea pigs Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Cryptotanshinone attenuates airway Inflammation induced by cigarette smoke in mice Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Inhibitors of apoptosis proteins in asthmatic airway inflammation Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014